# Zinc Effect on Inflammation and Cardiovascular Risk in HIV

> **NCT05085834** · EARLY_PHASE1 · COMPLETED · sponsor: **University Hospitals Cleveland Medical Center** · enrollment: 95 (actual)

## Conditions studied

- Inflammation
- Cardiovascular Diseases
- Zinc Deficiency

## Interventions

- **DRUG:** Zinc Gluconate
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05085834
- **Lead sponsor:** University Hospitals Cleveland Medical Center
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-01-22
- **Primary completion:** 2024-08-02
- **Final completion:** 2024-08-02
- **Target enrollment:** 95 (ACTUAL)
- **Last updated:** 2025-06-12

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05085834

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05085834, "Zinc Effect on Inflammation and Cardiovascular Risk in HIV". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05085834. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*